Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Alstrom Syndrome

• Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Patients With Moderate to Severe Obesity
• Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome
• Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
• Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome